Trial · NCT02713594
Wisconsin Tobacco Quit Line Medicaid Incentive Evaluation
NCT02713594, Not applicable, Completed, University of Wisconsin, Madison; results first posted 2017-04-21
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Wisconsin Tobacco Quit Line Medicaid Incentive Evaluation. Trials, record NCT02713594. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02713594
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Wisconsin Tobacco Quit Line Medicaid Incentive Evaluation
- NCT number
- NCT02713594
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 1,900 participants, actual
- Lead sponsor
- University of Wisconsin, Madison
- Conditions
- Smoking, Smoking Cessation, Nicotine Dependence
- Interventions
- Counseling from WTQL, Financial incentive to participate
- First posted
- 2016-03-18
- Last updated
- 2017-04-21
- Results first posted
- 2017-04-21
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Abstinence From Smoking | Measured 6 months after enrollment at follow-up assessment | The primary outcome data will be the biochemically confirmed abstinence using urine (measured cotinine) or exhaled (breath) carbon monoxide (CO). |
| Secondary | Engagement in Treatment | Measured 6 months after enrollment at follow-up assessment | This analysis will compare number of calls completed |
| Secondary | Cost-effectiveness | Measured 6 months after enrollment | This analysis will quantify the costs of treatment for Control and Incentive conditions with regard to attaining 6-month abstinence. Project costs were allocated to three categories: 1) Service costs, including billed staff time for counseling and testing, as well as all incidentals connected with services; 2) Incentives and distribution costs; and 3) Service-related administrative costs, including promotion/marketing and staff time for administering the intervention. Costs of planning the project, grant administration, and research within the project are not included in the analysis.The outcome is the cost per quit in each treatment group. Cost per quit in each group was calculated by: 1) computing the grand total of costs for all participants in a given group; and 2) dividing the grand total for a given group by the number of successful quitters. As such, the cost per quit is a single value with no measure of dispersion. |
Source ClinicalTrials.gov
Outcomes3
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Abstinence From Smoking | Measured 6 months after enrollment at follow-up assessment | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Engagement in Treatment | Measured 6 months after enrollment at follow-up assessment | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Cost-effectiveness | Measured 6 months after enrollment | U.S. Dollars | NUMBER |
Source ClinicalTrials.gov
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Abstinence From Smoking | Control | 131 | Participants | ||
| Abstinence From Smoking | Incentive | 205 | Participants | ||
| Engagement in Treatment | Control | Zero Calls Taken | 6 | Participants | |
| Engagement in Treatment | Incentive | Zero Calls Taken | 3 | Participants | |
| Engagement in Treatment | Control | 1 Call Taken | 245 | Participants | |
| Engagement in Treatment | Incentive | 1 Call Taken | 76 | Participants | |
| Engagement in Treatment | Control | 2 Calls Taken | 179 | Participants | |
| Engagement in Treatment | Incentive | 2 Calls Taken | 113 | Participants | |
| Engagement in Treatment | Control | 3 Calls Taken | 154 | Participants | |
| Engagement in Treatment | Incentive | 3 Calls Taken | 122 | Participants |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Control | 952 | |
| Overall Study | STARTED | Incentive | 948 | |
| Overall Study | COMPLETED | Control | 562 | |
| Overall Study | COMPLETED | Incentive | 552 | |
| Overall Study | NOT COMPLETED | Control | 390 | |
| Overall Study | NOT COMPLETED | Incentive | 396 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Control | ||
| Total, all-cause mortality | Incentive | ||
| Total, other adverse events | Control | 0 | 0 |
| Total, other adverse events | Incentive | 0 | 0 |
| Total, serious adverse events | Control | 0 | 0 |
| Total, serious adverse events | Incentive | 0 | 0 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 29079405 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Incentive vs Control: Abstinence From Smoking |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02713594
GET https://conductscience.org/api/trials/v1/NCT02713594/registered